AHITX | RTEHX | AHITX / RTEHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 37 years | 10 years | - |
Gain YTD | 8.965 | 8.603 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.5B | 22.5B | 100% |
Annual Yield % from dividends | 6.44 | 6.05 | 106% |
Returns for 1 year | 15.18 | 14.72 | 103% |
Returns for 3 years | 11.70 | 10.33 | 113% |
Returns for 5 years | 32.62 | 29.86 | 109% |
Returns for 10 years | 59.09 | 52.77 | 112% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MMRFX | 12.21 | N/A | N/A |
MassMutual Select TRP Real Asset I | |||
NGDCX | 28.77 | -0.18 | -0.62% |
Neuberger Berman Large Cap Growth C | |||
TRZLX | 45.24 | -0.29 | -0.64% |
T. Rowe Price US Large-Cap Core Z | |||
SEMGX | 18.36 | -0.20 | -1.08% |
DWS Emerging Markets Equity S | |||
FTDZX | 150.61 | -3.38 | -2.19% |
Franklin Biotechnology Discovery Adv |